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Abstract MicroRNAs (miRNAs) constitute a class of
small, non-coding RNAs that act as post-transcriptional
regulators of gene expression. In neurons, the functions of
individual miRNAs are just beginning to emerge, and
recent studies have elucidated roles for neural miRNAs at
various stages of neuronal development and maturation,
including neurite outgrowth, dendritogenesis, and spine
formation. Notably, miRNAs regulate mRNA translation
locally in the axosomal and synaptodendritic compart-
ments, and thereby contribute to the dynamic spatial
organization of axonal and dendritic structures and their
function. Given the critical role for miRNAs in regulating
early brain development and in mediating synaptic plas-
ticity later in life, it is tempting to speculate that the
pathology of neurological disorders is affected by altered
expression or functioning of miRNAs. Here we provide an
overview of recently identiﬁed mechanisms of neuronal
development and plasticity involving miRNAs, and the
consequences of miRNA dysregulation.
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Introduction
Synaptic development and plasticity are essential processes
for ﬁne-tuning brain circuitry during development, and for
learning, memory, and cognition. A number of develop-
mental and adult brain disorders are associated with
abnormal changes in synaptic connectivity and plasticity,
including fragile X syndrome (FXS) and autism [1]. Pre-
vious studies have indicated that synaptic plasticity is
under tight control via a number of different post-tran-
scriptional mechanisms, such as the ubiquitin–proteasome
system [2], translation initiation and elongation [3], and
miRNAs [4]. miRNAs have emerged as an important class
of small non-coding RNAs, which are highly conserved
and involved in a subset of biological processes such as
developmental timing, cell proliferation, apoptosis,
metabolism, cell differentiation, and morphogenesis [5].
They act to control the expression of sets of genes and
entire pathways, and are thus thought of as master regu-
lators of gene expression [6]. A few miRNAs are expressed
in mammalian brains speciﬁcally, suggesting unique reg-
ulatory roles in neuronal development and higher brain
function [7]. Recent estimates put the number of human
miRNAs at 1100 or more, composing complex regulatory
networks that inﬂuence the expression of as many as two-
thirds of all genes [8]. Such a large family of genes could
explain some of the difﬁculties that neurobiologists gen-
erally have encountered in their efforts to link individual
miRNA genes to mental disorders. Because they are single
molecular entities that dictate the expression of funda-
mental regulatory pathways, miRNAs represent potential
drug targets of unprecedented power. Here, we review
recent progress in our understanding of the post-tran-
scriptional mechanisms of miRNAs during neuronal
development and plasticity. We will emphasize the role of
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123miRNAs in regulating pre- and post-synaptic protein syn-
thesis systems essential for long-lasting memory formation
in the brain.
miRNA biogenesis and function
Although most miRNAs are encoded in intergenic regions,
miRNA genes are also found in introns or exons of non-
coding RNA genes, or within introns of protein-coding
genes [9]. The miRNA pathway starts in the nucleus with
the RNA polymerase II-mediated transcription of primary
(pri-) miRNAs which can be several kilobases (kb) in size
(Fig. 1). The stem-loop conformation of pri-miRNAs is
recognized by the nuclear protein Drosha. With its RNase
III activity, it cleaves the pri-miRNA into a precursor (pre-)
miRNA of around 70–80 nucleotides (nts). The speciﬁc
processing by Drosha is directed by DiGeorge syndrome
critical region 8 (DGCR8) protein [10, 11]. DGCR8
increases the activity of Drosha eight fold [11]. Similar to
Drosha knockdown (KD), the KD of DGCR8 leads to the
accumulation of pri-miRNAs and a decrease in the amount
of pre-miRNAs [10, 11]. The Drosha/DGCR8 complex
generates a pre-miRNA with a 2 nt 30 overhang [12, 13]
and a stem-loop conformation ideally consisting of
*22 nts, which will become the mature miRNA later on in
the maturation pathway [13]. The characteristic 30 over-
hang and stem-loop conformation are essential for miRNA
recognition by exportin-5, which transports the pre-miRNA
from the nucleus to the cytoplasm with high efﬁciency in a
Ran/GTP-dependent manner [12]. Although the majority of
miRNAs are processed by Drosha, there is also miRNA
population that bypasses the Drosha/DGCR8 enzyme
complex. One of the miRNA subclasses, known as
‘‘miRtrons’’, is encoded in the introns of protein-coding
genes, and mimics the structural features of pre-miRNAs.
miRtrons are spliced out to form pre-miRNAs that can be
further processed through the common miRNA processing
cascade [14–17]. Also, shRNA-derived miRNAs and
endogenous hairpin-derived siRNAs are processed in a
Drosha-independent manner. The expression patterns as
well as the functions of these subclasses of miRNAs and
Fig. 1 The biogenesis of miRNAs. Pri-miRNAs are transcribed from
intergenic genes and later capped and polyadenylated. Alternatively,
miRNAs transcription can occur from genes coded within introns of
coding or non-coding genes. Pri-miRNA transcripts are processed into
a pre-miRNA by the Drosha/DGCR8 complex, creating a
*70–80 nts, hairpin-looped molecule, which is then shuttled out of
the nucleus via the exportin-5 mediated transport. Some intronic-
encoded miRNAs evade nuclear processing prior to nuclear export.
Cytoplasmatic digestion of the pre-miRNA is facilitated by Dicer,
resulting in double-stranded mature miRNAs. Mature miRNAs
modulate gene expression by associating with Argonaute-containing
complexes to form the RNA induced silencing complex (RISC). By
imperfectly or near-perfectly base pairing with sequences in the 30
UTRs of target mRNAs, miRNAs modulate gene expression through
transcript destabilization and translational attenuation. Alternatively,
mRNA deadenylation and decapping precedes mRNA cleavage, a
process depending on the degree of base-pairing [126]. Some
miRNAs can enhance translation upregulation of target mRNAs on
cell cycle arrest, while repressing translation in proliferating cells
[127]
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123siRNAs in mammalian somatic tissues is a yet unexplored
area [14]. Moreover, different subclasses of small nucleolar
RNAs (snoRNAs), which fulﬁll miRNA-related functions
outside of the nucleolus, are found to be processed inde-
pendently of Drosha.
In the cytoplasm, pre-miRNAs are recognized and pro-
cessed by the RNase III Dicer. Dicer KO in Caenorhabditis
elegans [18, 19] and mammalian cell lines [20] resulted in
the accumulation of cytoplasmatic pre-miRNA. This was
ﬁrst demonstrated for let-7, a miRNA highly conserved
among many species, with an essential role in develop-
mental timing in C. elegans and Drosophila [18–21], and
prominently involved in many forms of cancer [21]. Fragile
X mental retardation protein (FMRP) interacts with RNAs
of around 80 nts and with Dicer in vivo. The complex
immunoprecipitated with anti-FMRP antibodies is able to
process the long double-stranded pre-miRNAs into mature
miRNAs of around 22 nts [23]. An exception on this Dicer-
dependent miRNA processing is miR-451, which instead
uses AGO2 slicer catalytic activity in order to be processed
into a mature miRNA. The use of this alternative pro-
cessing pathway is accomplished by the structural
conformation of miR-451 [25]. Once processed into their
mature form, miRNAs enter the miRNA silencing complex
(miRISC) to degrade or silence mRNAs. During this pro-
cess, the miRISC complex is supported by a set of proteins,
among which Argonaute (AGO)1, AGO2, Pumilio2
(Pum2), and Moloney leukemia virus (MOV10). Within
this miRISC complex, AGO1 directly associates with
miRNAs [22], and in addition interacts with FMRP [23].
Similarly, AGO2 interacts with mature miRNAs captured
in the miRISC complex, and suppression of AGO2 reduced
the ability of cells to silence exogenous reporters [24].
Each miRISC-incorporated mature miRNA can act on
the expression levels of many mRNAs and conversely
individual mRNAs can be targeted by a number of miR-
NAs. This allows for vast combinatorial complexity that
could partly account for the genetic complexity associated
with a multitude of essential biological processes. While
mRNA targeting and regulation in plants requires a near-
perfect complementarity between mature miRNA and the
target mRNAs, in animals miRNAs regulate gene expres-
sion by imperfect or near-perfect base pairing to mostly the
30 untranslated region (UTR) of target mRNAs, thereby
inhibiting protein synthesis or causing mRNA degradation
[26]. miRNA-mediated translational inhibition or mRNA
degradation in addition depends on the 50 cap region of the
target mRNAs, since it was shown that miRNAs are able to
inhibit the translation of m7G-capped mRNAs but not of
mRNAs with an internal ribosome entry site or with a non-
functional ApppN cap [27, 28]. In eukaryotic cells,
mRNAs are circularized by initiation factors, among which
eIF4E and poly(A)-binding protein 1 [29]. AGO proteins
stimulate miRNA-dependent inhibition of translation by
competing with eIF4E for the 50 cap binding site, thereby
preventing circularization of the mRNA and thus lowering
the initiation efﬁciency and at the same time sensitizing the
poly(A) tail for exonuclease [28].
Neuronal localization of miRNAs
The expression of miRNAs in the brain can be ubiquitous
or restricted to a speciﬁc brain region, e.g., the hippo-
campus, cortex, or amygdala [30–32]. This regional
speciﬁcity in miRNA expression reﬂects the differences in
mRNA composition of cells within various brain tissues
and their need for a selection of miRNAs. This notion
offers the possibility to establish cell- and tissue-speciﬁc
miRNA functions by identifying their target mRNAs.
Several recent studies have shown subcellular localization
of miRNAs within neuronal dendrites of the forebrain [33]
and the hippocampus [34]. In synaptoneurosomes, repre-
senting the dendritic spines of the neuronal cells, pre-
miRNA levels are high in comparison to the levels of
mature miRNAs. In synaptosomes consisting mainly of
axon terminals and the adherent post-synaptic densities,
pre-miRNAs are enriched as well. miRNAs are thus
delivered at the synapse predominantly in their premature
forms, destined to be processed locally in correspondence
with neuronal conditions [33]. miR-26a was found to be
one of the miRNAs most enriched in the dendrites.
Sequence-speciﬁc miRNA KD identiﬁed microtubule-
associated protein 2(MAP2) mRNA as a target for miR-26a.
This miRNA reduces microtubule assembly during syn-
aptic plasticity through inhibition of MAP2 mRNA
translation [34].
miRNAs have been shown to be present in the axonal
compartments where they can actively regulate local
mRNA translation. Key proteins involved in the RNAi/
miRNA pathway, i.e., miRISC complexes, can assemble
and function in developing axons [35]. Recently, Natera–
Naranjo [36] and colleagues employed compartmentalized
Campenot cell culture chambers to obtain a pure axonal
RNA fraction of superior cervical ganglia (SCG) neurons,
and determined the miRNA expression levels in these
subcellular structural domains. Their data revealed stable
expression of a number of mature miRNAs that were
enriched in the axons and at presynaptic nerve terminals.
Among the 130 miRNAs identiﬁed in the axon, miR-15b,
miR-16, miR-204, and miR-221 were found to be highly
abundant in distal axons as compared to the cell bodies.
Interestingly, a number of miRNAs encoded by a common
pri-miRNA transcript were differentially expressed in the
distal axons, suggesting that there is a differential subcel-
lular transport of miRNAs derived from the same coding
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123region of the genome. In addition, Aschraﬁ et al. [37] used
the same compartmentalized cell culture setting and iden-
tiﬁed miR-338 as a novel modulator of the intra-axonal
translation of cytochrome c oxidase IV (COXIV) mRNA, a
nuclear-encoded mitochondrial protein that plays a rate-
limiting role in the assembly of the mitochondrial enzyme
complex IV and in oxidative phosphorylation. Regulation
of axonally localized COXIV mRNA by miR-338 resulted
in a decrease in mitochondrial activity, as measured by the
reduction of cellular oxygen consumption and ATP levels.
Despite increasing evidence for the existence of miRNAs
in axons obtained from cell culture experiments, the in vivo
relevance of axonal miRNAs in local translation is still
unknown. Moreover, little is known about the mechanism
of selective miRNA transport into neuronal endings [38].
Molecular basis of local synaptic translation
While the majority of neuronal mRNAs are translated in
the neuronal soma, increasing evidence from more than
three decades of neurobiological research suggests that a
fraction of the neuronal transcriptome is selectively trans-
ported to distal domains of the neuron. The local
translation of these mRNAs has a key role in neuronal
development, including neuronal survival [39], navigation
of the axon [40–45], axonal regeneration [46, 47], synapse
formation [48], and activity-dependent synaptic plasticity
[49–52]. Notably, a fundamental observation in the ﬁeld of
learning and memory is that new proteins must be syn-
thesized locally at the synapse in order to consolidate
newly formed memories [53]. In addition, several Men-
delian forms of intellectual disability, such as FXS are
caused by changes in synaptic plasticity as a major cellular
correlate of their neuropathological phenotypes [54]. As
with memory, the stabilization of several distinct forms of
activity-dependent synaptic plasticity requires a wave of
post-synaptic protein synthesis in the dendrites of neurons.
Each form of synaptic plasticity has very distinct charac-
teristics, such as the activation of speciﬁc signaling
cascades and receptor internalization or surface expression,
suggesting that different sets of proteins are required to
consolidate the different forms of plasticity [55]. mRNA
transport and subsequent protein synthesis at speciﬁc syn-
aptic sites allow regulation at the level of individual
synapses, a process required for proper neuronal and
behavioral plasticity [56–61]. The local distinction between
synapses that undergo long-term potentiation (LTP) and
synapses that do not, lies within the ability of a synapse to
use the proteins made upon neuronal stimulation: only
synapses that receive neuronal stimuli will be able to use
the proteins made by the activity-induced transcription [59,
62]. The advantage of site-speciﬁc translation is that only a
few mRNA copies have to be transported to the synapses
which in turn can be translated multiple times, whereas
multiple proteins produced in the soma from the same
mRNA would have to be transported to the synapses [63].
Regulation of local mRNA translation alters the synaptic
protein content upon neuronal stimulation by changing the
amount of proteins, by changing the entire synaptic prote-
ome through alterations in protein abundance relative to
each other, or by the expression of protein isoforms [56,62].
Many studies have identiﬁed a number of mRNAs
localized in the dendrites of neurons and thus representing
candidates being linked to synaptic plasticity [34, 64–66].
These dendritic mRNAs encode proteins involved in mul-
tiple cellular processes regulating spine activity, including
signal transduction, mRNA translation, protein transport
and degradation, cytoskeleton regulation, and RNA binding
and silencing. Among the locally synthesized signaling
pathway components are the mitogen-activated protein
kinase (MAPK), calcium/calmodulin-dependent protein
kinase (CaMK) and protein kinase C (PKC) pathways,
which are needed for the induction of morphological
changes in synaptic connections and for the maintenance of
LTP [65]. Importantly, mRNAs encoding proteins that are
essential for translation are also dendritically localized,
such as mRNAs coding for the eukaryotic initiation factors
eIF4c2, eIF3 and eIF5 [64], and elongation factors EF1a,
EF2 [64] and eEF1A [65], suggesting that local translation
is tightly regulated at multiple levels. Furthermore,
mRNAs encoding proteins that participate in neuronal
outgrowth and spine formation were detected at the spines,
among which FMRP, Pum2, and activity-regulated cyto-
skeleton-associated protein (Arc). FMRP is required for
activity-dependent translation [60], Pum2 regulates eIF4E-
dependent mRNA translation, dendritic morphology and
neuronal excitability, and Arc is involved in a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPAR) internalization. For neurite outgrowth, also
cytoskeletal remodeling is required, a process regulated by
the locally translated MAP2 [65]. Furthermore, CaMKII
and post-synaptic density 95 (PSD-95), fulﬁlling a scaf-
folding function at post-synaptic spines, were found to be
locally expressed [34].
miRNAs are involved in synaptic maturation
and plasticity
Several studies address the importance of miRNAs in
neuronal differentiation and synaptic functionality using
KO models of Dicer or DGCR8. Dicer ablation in mice
causes impaired neuronal differentiation, reduction in
neuronal size, loss of branching and disturbed axonal
pathﬁnding [67–69]. DGCR8 KO mice display deﬁcits in
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123synaptic connectivity due to a reduction in the number and
size of dendritic spines, reduced synaptic complexity and
impaired synaptic transmission [70]. However, by knock-
ing out Dicer or DGCR8 the major part of miRNA
processing is blocked, giving an indication of the functions
of miRNAs in general. In contrast, studies using single
miRNA KD provide a more speciﬁc way to investigate the
role of individual miRNAs throughout neuronal differen-
tiation steps or during synaptic activation.
Recent ﬁndings from studies using single RNA KD also
indicate that miRNAs may be involved in modulating local
translation and consequently long-term synaptic plasticity
(Table 1). The miRISC protein MOV10 regulates miRISC-
associated synaptic mRNAs like CaMKII, lim-domain-
containing protein kinase 1 (Limk1) and lysophospholipase
1 (Lypla1). Synaptosomal preparation studies have shown
that upon N-methyl-D-aspartate receptor (NMDAR) acti-
vation, MOV10 is degraded at the synapses, allowing the
translation of synaptic mRNAs that are important for
synaptic plasticity [71]. Mature and precursor miRNAs are
also located in the soluble component of biochemically
isolated synaptic fractions [33]. This ﬁnding raises the
possibility that miRNAs are formed locally via the pro-
cessing of pre-miRNAs within dendritic spines.
Upon induction of LTP or long-term depression (LTD),
several miRNAs are upregulated in the adult mouse hippo-
campus. Most miRNAs are rapidly upregulated within
15 min after chemical LTP or metabotropic glutamate
receptor (mGluR)-dependent LTD induction. While the
majority of the miRNAs have been shown to be upregulated
by bothLTP and LTD,temporalexpression patterns seemto
differ between these two forms of plasticity [72]. Following
high frequency stimulation in the dentate gyrus (DG), miR-
132 and miR-212 are upregulated [73]. In the adult DG,
transcription of pri-miR-132 and pri-miR-212 strongly
depends on mGluR, rather than NMDAR activation.
Recently,GoodmanandassociatescreatedaconditionalKO
mouse lacking miR-132 and/or miR-212, and examined the
involvementofthesemiRNAsinthematuration ofdendrites
ofnewbornneuronsintheadulthippocampus.Simultaneous
deletion of the miR-132/212 genes caused a dramatic
decrease in dendritic length, arborization, and spine density.
Out of the miRNAs generated from this locus, miR-132 is
proposed to be the miRNA responsible for normal dendrite
maturation in newborn hippocampal neurons. Also, ablation
of miR-132/212 has similar effects on dendritic develop-
ment as the loss of cAMP response element-binding
(CREB), and miR-132 inhibitors can block the effects of
CREB on dendritic maturation, suggesting that miR-132 is
involved in CREB signaling [74].
KO studies targeting miR-124 [75], miR-125b [76],
miR-132 [77], miR-134 [78, 79], miR-137 [80], and miR-
138 [81], convincingly revealed the roles of these miRNAs
in synaptic development and dendritic arborization. miR-
124 is the most abundant miRNA in the mouse brain as it
accounts for 25–48% of all brain-expressed miRNAs [82].
Transfection of mouse neuronal stem cells with miR-124
stimulates neuron-like differentiation by promoting neu-
ron-speciﬁc neuron-speciﬁc class III beta-tublin 1 (Tuj1)
and MAP2 expression, and causing G0/G1 cell cycle arrest
[83]. In differentiating mouse P19 cells as well as in pri-
mary cortical neurons, miR-124 targets the Rho GTPase
family. By targeting cell division cycle 42 (Cdc42) and
deactivating ras-related C3 botulinum toxin substrate 1
(Rac1) of the Rho GTPase family, miR-124 diminishes
F-actin density and stimulates tubulin acetylation and
possibly regulates cytoskeletal reorganization, resulting in
the stimulations of neuronal outgrowth (Fig. 2)[ 84].
In vivo experiments in the mouse subventricular zone
(SVZ) have demonstrated that miR-124 downregulates
SRY-box containing gene 9 (Sox9) and thereby inhibits
precursor division and stimulates differentiation [75].
Overall, miR-124 appears to play a major role in neuronal
differentiation by downregulating genes essential for pre-
cursor proliferation, while stimulating neuron-speciﬁc
genes and cytoskeletal rearrangements.
Recently, miR-132 was shown to repress translation of
p250GAP, an NMDAR receptor-associated Rho GTPase-
activating protein (GAP), which regulates spine morpho-
genesis by modulating Rac1 and/or RhoA (Fig. 2).
miR-132 expression in rat hippocampus is low during the
ﬁrst postnatal week but accelerates between day 7 and 21,
correlating with a period of active synaptogenesis. Con-
versely, p250GAP expression is high early in development
and decreases during maturation. In organotypical hippo-
campal neurons, inhibition of miR-132 attenuates activity-
induced spine formation and decreases spine head size,
whereas introduction of miR-132 was sufﬁcient to increase
spine formation. Likewise, KD of p250GAP increases
spine density and spine size, and furthermore increased
both mEPSC frequency and the number of GluR1-positive
spines. Additionally, miR-132/p250GAP signaling regu-
lates Rac1 activity and spine formation by modulating
synapse-speciﬁc kalirin7/Rac1/Pak signaling [85]. Notably,
miR-132 together with miR-125b were recently shown to
form a functional interaction with FMRP [76] (see below).
Overexpression of miR-132 led to an increase in mean
mEPSC amplitude and frequency, a phenotype that was
prevented by the KD of FMRP. These data suggest that,
through the regulation of p250GAP and Rac1 signaling,
FMRP and miRNA-132 can cooperate to control synaptic
structure and function and potentially explain the spine and
behavioral phenotype observed in FXS patients. Indeed, a
few reports have linked FMRP’s effect on spine mor-
phology to the Rac1 GTPase signaling pathway. The
mRNA encoding Rac1 was found to be present in
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123Table 1 An overview of selected miRNAs involved in neuronal growth and plasticity
miRNA Neuronal function mRNA target Reference
miR-9 Directs ES cells towards a neuronal state Phospho-STAT3
a [91]
miR-9 Enhances differentiation of neuronal stem cells TLX [92]
Attenuates neural proliferation
Promotes neuronal migration in the developing cortex
miR-9 Promotes Cajal-Retzius cell differentiation Foxg1 [93, 94]
Regulates neurogenesis Gsh2
miR-9 KO mice show impaired brain development
miR-124 Negative constraint on serotonin-induced long-term facilitation CREB1 [115]
Converts short-term to long-term synaptic facilitation
miR-124 Increases the number of primary neurites in cortical neurons Cdc42
a [84]
Rac1
a
miR-124 Promotes neuronal differentiation of neuronal stem cells CDK6 [83]
Stimulates neurite branching
Increases the level of neuronal marker Tuj1
miR-125b FMRP-associated NR2A [76]
Stimulates dendritic branching EphA4
Reduces spine width
Weakens synaptic transmission
miR-128 Promotes neuronal differentiation UPF1 [95]
Enhances dendrite outgrowth MLN51
miR-132 Induces neural outgrowth [77]
miR-132 Expression is regulated by CREB [74]
Increases dendritic length, branching, and spine density
Neuronal development and maturation in vivo
miR-132 FMRP-associated [76]
Stimulates dendritic complexity
Increases spine width
Strengthens synaptic transmission
miR-132 Induces activity-dependent dendritic growth p250GAP [85]
Triggers de novo spine formation Rac1
a
Stimulates synaptic transmission Kalirin-7
a
miR-132 Expression is upregulated by BDNF Upregulation of glutamate receptors
NR2A
a, NR2B
a, and GluR1
a
[116]
miR-134 Modulates cortical development in
a stage-speciﬁc manner
Chrdl-1 [117]
Dcx
miR-134 Decreases spine size LIMK1 [78]
miR-134 Expression is modulated by SIRT1 Inhibits translation of CREB [79]
Impairs synaptic plasticity/LTP
miR-137 Increases the level of neuronal marker Tuj1 CDK6 [83]
miR-137 Inhibits spine development and phenotypic maturation Mib1 ubiquitin ligase [80]
miR-138 Regulates spine size negatively APT1 [71, 81]
Decreases the amplitude of post-synaptic currents
Decreases in AMPAR cluster size
miR-219 Expression is downregulated by an NMDAR antagonist CaMKII [108]
miR-375 Represses the density of dendrites HuD [118]
Diminishes the appearance of neurites after BDNF stimulation
miR-379/410 cluster Transcribed by activation of Mef2 Pumilio2 (by miR-134) [89]
Inhibits dendritic outgrowth
a No direct expression regulation via the identiﬁed miRNA shown
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123fmr1-messenger ribonucleoprotein complexes [86], and
fmr1 and Rac1 genetically interact in Drosophila. The
fmr1-interacting proteins cytoplasmic fmr1 interacting
protein (dCYFIP) and dRac1 [87] biochemically and
genetically interact, these three proteins converge into
common pathways controlling axonogenesis and synapto-
genesis. Evidence was further presented that Rac1
negatively regulates CYFIP, which in turn negatively
regulates fmr1, with the net result that dRac1 positively
regulates dFMR1 action on neuronal morphogenesis [87].
Since FMRP-mediated repression of translation requires an
interaction with CYFIP1 and the interaction of CYFIP1
with the translation initiation factor eIF4E [87, 88]i ti s
tempting to speculate that the Rac1/FMRP/CYFIP/elF4E
signaling provides a bridge between activity-dependent
cytoskeleton remodeling and translation. This is of interest
since neuronal plasticity requires both actin cytoskeleton
remodeling and local protein translation in response to
extracellular signals. Also of interest is the observation that
brain-derived neurotrophic factor (BDNF)-induced miR-
132 upregulates glutamate receptors at the synapse. Thus,
further supporting the notion that miR-132 is central in
controlling synaptic structure and function.
Through a functional screen Siegel et al. recently iden-
tiﬁed a novel miRNA that is important for spine
morphogenesis. miR-138 is localized in dendrites of rat
hippocampal neurons [31, 32] and alters synaptic excit-
ability by decreasing the size of GluR2-containing
AMPAR clusters and AMPAR-dependent synaptic trans-
mission. Furthermore, miR-138 inhibits spine growth
through local suppression of acyl protein thioesterase 1
(APT1), which in turn catalyzes depalmitoylation of
proteins, thereby modulating their membrane association.
One possible mechanism is that miR-138 activates the Rho
signaling pathway by promoting membrane association of
Ga12/13, one of the targets of APT1 (Fig. 2). Although a
direct link between miR-138 and Rho has not been estab-
lished yet, through membrane association the small G
protein subunit Ga13 has been shown to be involved in
Rho-dependent signaling [81].
In the rat hippocampus, miR-134 levels increase during
development, reaching maximum expression levels at P13,
when synaptic maturation occurs. Neurogenic differentia-
tion factor 2 (NeuroD2), disks large homolog 2 (DLG2),
and Limk1 contain target sequences for miR-134. Limk1
regulates actin ﬁlament dynamics, thereby controlling
cytoskeletal reorganizations essential in spine outgrowth.
While targeting of Limk1 by miR-134 inhibits spine
growth, BDNF increases the synthesis of the Limk1 protein
by relieving the miR-134 suppression via the TrkB/mTOR
pathway (Fig. 2). KD with a miR-134 antisense oligonu-
cleotide increases spine volume and width in primary rat
hippocampal neurons [78]. Thus, an interesting theme is
emerging in which miRNAs play an important role in
synapse development and plasticity by controlling actin
cytoskeleton remodeling through Rho GTPase signaling
[89]. Since both miR-132 and miR-134 are regulated by
activity at the transcriptional level, these data also indicate
that Rho signaling can be ﬁne tuned in an activity-depen-
dent manner. Since only a small number of miRNA targets
have been validated and shown to be functionally impor-
tant in vivo so far [90], it will thus be interesting to assess if
more Rho signaling proteins are controlled by miRNAs at
the level of (local) translation.
Fig. 2 Overview of miRNAs involved in post-synaptic spine growth
or shrinkage with several implicated downstream pathways. The
indicated miRNAs can modulate the spine morphologies by targeting
components of the actin cytoskeleton, regulate protein expression by
targeting transcription factors or (indirectly) targeting components of
synaptic ion channels. The molecules involved have been color-
coded, and where red proteins are direct targets of miRNAs, blue
proteins depict downstream molecules within the pathways and green
proteins are upregulated by miRNAs
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123It was recently demonstrated that NAD-dependent his-
tone deacetylase sirtuin 1 (SIRT1) has the capacity to
modulate synaptic plasticity through miRNA-134-depen-
dent regulation of the CREB protein [79]. Previously,
SIRT1 was shown to have a number of functions linked to
cell metabolism and cellular stress responses. Tsai and
associates generated transgenic mice that lack SIRT1
deacetylase activity in the brain. These mice exhibited
impaired LTP in CA1 neurons and deﬁcits in memory
performance. SIRT1 binds to regulatory DNA sequences
upstream of the miR-134 locus and inhibits miR-134
expression upon binding. Furthermore, loss-of-function
mutants of SIRT1 inhibited CREB activity in vitro. Addi-
tion of miR-134-inhibiting oligonucleotides restored CREB
activity, indicating that SIRT1 loss-of-function impairs
CREB activity through a miR-134-mediated mechanism.
The authors overexpressed miR-134 in CA1 neurons to
assess the role of miR-134 in synaptic plasticity. miR-134
overexpression impaired hippocampus-dependent memory
formation in wild-type mice and LTP induction in hippo-
campal slice cultures, suggesting that overexpression of
this miRNA in CA1 neurons mimics the effects of SIRT1
loss-of-function. The results of this elegant study indicate
that SIRT1 has a key role in synaptic plasticity and
memory formation by regulating the protein levels of
CREB through miR-134-mediated repression [79].
An example of a miRNA involved in development is
miR-9, which was shown to be upregulated during differ-
entiation of mouse embryonic stem (ES) cells towards a
neural precursor state, suggesting a role for this miRNA in
neuronal differentiation. Overexpression of miR-9 directed
ES cells towards a neuronal state versus astroglial cells
[91]. Zhao and colleagues provided further evidence for the
involvement of miR-9 in differentiation by utilizing in
utero electroporation to overexpress miR-9 in the devel-
oping brain. miR-9 introduction altered migration and
premature differentiation of embryonic neural stem cells
lining the ventricular zone. Furthermore, miR-9 was shown
to regulate tailless gene (TLX), a gene involved in the
division of neural stem cells. Inhibition of TLX by miR-9
attenuated neural stem cell proliferation while enhancing
differentiation. Interestingly, TLX was found to inhibit
miR-9-1 expression by binding to a 30 genomic sequence,
effectively forming a feedback loop regulation during
neuronal differentiation [92]. Besides differentiation of ES
cells, miR-9 was found to promote generation of Cajal-
Retzius cells in the medial pallium of the developing
telencephalon through negative regulation of the forkhead
box protein G1 (foxg1) gene [93]. These ﬁndings were later
conﬁrmed and extended by the generation of a miR-9 KO
mouse model [94]. Together, these ﬁndings suggest miR-9
as a central regulator of early developmental processes,
during which this miRNA modulates the differentiation
and migration of ES cells leading to proper formation of
speciﬁc brain areas.
Recently, Bruno and associates revealed that overex-
pression of miR-128 activates the expression of genes
relevant for neurogenesis and neuronal differentiation
through disruption of the non-sense-mediated RNA decay
(NMD) machinery. miR-128 has the capacity to modulate
neuronal differentiation through upregulation of a battery
of NMD target genes, by speciﬁcally diminishing the levels
of the NMD proteins RNA helicase Regulator of Non-sense
Transcripts 1 (UPF1), and metastatic lymph node 51
(MLN51) [95].
miRNA expression is linked to learning behavior
in rodents
Parsons and colleagues gave a ﬁrst indication of the
involvement of speciﬁc miRNAs in learning and memory,
exploration, and anxiety behavior [96]. Learning and
memory is associated with the expression of a number of
miRNAs, such as miR-34c, miR-323, miR-378, and miR-
451. Exploration behavior is correlated with the expression
of the same set of miRNAs, except for involvement of the
miR-34a-form instead of the c-form. Anxiety behavior is
associated with miR-34c and miR-323 expression. Finally,
miR-212 expression correlates with grooming duration in
anxiety tasks [96].
In another study, hippocampal miRNA expression
changes were assessed in mice subjected to an olfactory
learning paradigm. When the levels of individual miRNAs
were analyzed following training, expression of 14 miR-
NAs were elevated. Their mRNA targets were linked to
processes that included LTD, transcription, RNA binding,
and miRNA biogenesis pathways. Since whole hippocampi
were used for miRNA proﬁling, local synaptic miRNA
changes of trained animals could not be discriminated [97].
The studies summarized here indicate that miRNAs
expressed by hippocampal neurons are possibly involved in
hippocampus-dependent learning. Recent ﬁndings suggest
that in mice learning and memory is enhanced by the loss
of miRNAs in the brain. DCGR8 KO mice showed wild-
type behavior in the open ﬁeld test, but deﬁcits when
subjected to a prepulse inhibition test. In cognitive tasks,
these KO mice showed normal freezing in the contextual
and cued fear-conditioning. However, in the spatial work-
ing memory-dependent learning task DGCR8 KO mice
performance was impaired, thus indicating the involvement
of miRNAs in working memory function [70]. Konopka
and associates deactivated the gene for Dicer speciﬁcally in
forebrain neurons of adult mice. At 12 weeks of age, Dicer
KO mice showed improved learning and memory in
behavioral tests, and mutant neurons exhibited increased
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learning [98]. In vivo KD studies of miRNAs followed by
behavioral experiments would be an additional sophisti-
cated approach to delineate the roles of individual miRNAs
during experience-dependent plasticity.
miRNAs in neuronal maturation defects
and neurological diseases
Multiple lines of evidence suggest that altered neuronal
plasticity and morphology as seen in neurodevelopmental
disorders may result from disruption of a common post-
translational process that is under tight regulation by
miRNAs [99]. Several intellectual disability (ID) syn-
dromes, such as FXS, Rett syndrome and Down syndrome
have been linked to the miRNA pathway [23, 100, 101].
Increasing evidence suggests that miRNAs which act as
regulators of neuronal gene circuitries are associated with
complex neuropsychiatric disorders involving abnormali-
ties in synaptic plasticity, as well as neurodegenerative
diseases. Kosik and coworkers proﬁled human miRNAs in
autism and control post-mortem brains, and identiﬁed 28
miRNAs to be differentially expressed in autistic as com-
pared to healthy individuals [102]. Recently, a valproic
acid (VPA) rat model of autism was employed to assess the
molecular role of miRNAs in the chemically induced,
neuroplastic changes observed in autism spectrum disor-
ders (ASD). Chronic VPA treatment of adult rats induced
alterations of hippocampal miRNA levels. Levels of let-7,
miR-128a, miR-24a, miR-30c, miR-34a, miR-221 and
miR-144 were signiﬁcantly altered, and the predicted
effectors of these miRNAs are involved in neurite out-
growth, neurogenesis, signaling of PTEN, ERK, and Wnt/
beta-catenin pathways [103].
Trinucleotide expansions in the 50 UTR of the fmr1 gene
leading to reduced FMRP protein levels are associated with
FXS, characterized by intellectual disability and autistic
features. FMRP is involved in the miRNA pathway through
interaction with miRNA biogenesis components or through
association with miRNAs directly [104]. Interestingly,
Edbauer et al. showed that miR-125b and miR-132, as well
as several other miRNAs, are associated with FMRP in
mouse brain. More speciﬁcally, miR-125b and miR-132
had largely opposing effects on dendritic spine morphology
and synaptic physiology in hippocampal neurons. FMRP
KD ameliorates the effect of miRNA overexpression on
spine morphology, and NMDAR subunit NR2A was
identiﬁed as a target of miR-125b [76]. FMRP controls pre-
miR-124 processing into mature miR-124 [105]. Since
miR-124 stimulates neuronal differentiation [75, 83, 84],
its link with FMRP may suggest roles for this miRNA in
FXS patients.
In schizophrenia patients, miR-16b, 30b [106] and 181b
are signiﬁcantly upregulated in the prefrontal cortex [107].
miR-181b downregulates protein levels of the AMPA
glutamate receptor subunit GluR2 and of the RNA binding
protein visinin-like 1 (VSNL1). GluR2 stimulates excit-
atory neurotransmission and has direct effects on synaptic
plasticity by increasing growth and density of dendritic
spines. VSNL1 is stimulated by glutamate and targets the
mBDNF receptor TrkB thereby promoting neuronal mat-
uration. Upregulation of miR-181b in schizophrenia
patients thus causes a decrease in neuronal outgrowth by
targeting GluR2 and VSNL1 [107]. Recent research has
identiﬁed miR-219 as a key molecule in the behavioral
manifestations associated with NMDAR hypofunction,
which has been implicated in the pathophysiology of
schizophrenia [108], since acute treatment of mice with the
NMDAR antagonist dizocilpine resulted in downregulation
of miR-219 in mouse prefrontal cortex. Moreover, treat-
ment of mice with the antipsychotic drugs haloperidol or
clozapine attenuated the hyperactivity and prevented the
reduction in miR-219 in the prefrontal cortex. Notably,
infusion of mouse brain with the antisense oligonucleotides
(so-called antagomiRs [109]) against miR-219 both atten-
uated the locomotor and stereotypic behaviors caused by
dizocilpine and increased the expression of miR-219 target
CaMKII in the prefrontal cortex. This study suggests that
altered miR-219 levels could be a signiﬁcant factor in the
dysregulation of cortical gene expression in schizophrenia.
Extensively studied neurodegenerative diseases such as
Alzheimer’s disease (AD) and Parkinson’s disease (PD)
also display altered miRNA expression proﬁles. The
expression of the b-site of APP cleaving enzyme (BACE1)
protein stimulates the formation of amyloid-b-peptide
plaques in the brains of AD patients. BACE1 was shown to
be targeted by miR-485-5p. A natural antisense transcript,
BACE-antisense, however, blocks the binding site for
miR-458-5p thereby preventing BACE1-downregulation.
BACE-antisense and miR-458-5p compete for the binding
to BACE1-mRNA. In AD patients, BACE-antisense
appeared to be upregulated while miR-485-5p was down-
regulated in the entorhinal cortex and the hippocampus,
thus increasing the amount of BACE1 protein and thereby
amyloid-b formation in these brain regions [110]. Addi-
tional miRNAs that are dysregulated in AD are miR-9,
miR-138 and miR-125b, the levels of which are increased
in the CA1 region of the hippocampus [111].
The maturation of dopaminergic neurons is under the
control of miRNAs as well. In mice, induced deletion of
Dicer speciﬁcally in post-mitotic dopamine neurons yields
a phenotype comparable to that of PD patients, namely loss
of dopaminergic neurons and reduced locomotion. A spe-
ciﬁc miRNA involved in dopaminergic maturation is miR-
133b and its level is increased in PD [112]. miR133b
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(Pitx3), which is normally induced during neuronal
development. Pitx3 in addition upregulates miR-133b
expression, thus generating a feedback circuit. Overall,
upregulation of miR-133b expression in PD represses
neuronal maturation through the inhibition of Pitx3.
From these studies on neurological diseases, it thus
appears that miRNAs are essential in neuronal differentia-
tion, dendritic outgrowth, and spine formation. The
dysregulation of miRNAs could ultimately underlie some of
the clinical features observed in these diseases through their
effects on synaptic plasticity. An overview of miRNAs
implicated in neurological disorders is provided in Table 2.
Mutations in miRNA genes or gene copy number
changes due to genomic deletions and duplications are
likely to be involved in neurological disorders. So far, there
are no published examples to substantiate this notion, but
mutations in miR-96 have been linked to deafness in mice
[113]. Moreover, heterozygous mutations in the human
SLITRK1 gene have been associated with a variety of
neuropsychiatric features including Tourette syndrome,
ADHD, and compulsive hair pulling. In Tourette syndrome
a single mutation in the 30 UTR of SLITRK1 disrupts the
recognition site of miR-189 [114]. The same mutation was
also found in other families with Tourette syndrome and
obsessive compulsive disorder, but the mutation was not
fully segregated with the disorder, suggesting additional
genetic and/or environmental contributions to the disease.
Nonetheless, since mutation analysis in human disorders
have so far been largely restricted to coding sequences it is
to be expected that the rapidly emerging whole-genome
sequencing projects will reveal mutations in miRNA genes
or their target sequences in human neurodevelopmental
disorders.
Future directions
The unique feature of miRNAs is to modulate complex
physiological or disease phenotypes by regulating entire
genetic circuitries. The ﬁndings reviewed here support the
hypothesis that miRNAs are ideally positioned to play a
central role in regulating complex gene networks involved
in synaptic development and plasticity. This characteristic
makes miRNAs attractive and novel therapeutic and diag-
nostic targets for the treatment and detection of complex
intellectual disorders. Ultimately, further identiﬁcation of
individual miRNAs in synaptic function and maintenance
will generate original insights into the molecular basis of
synaptic plasticity. In the long term, the outcome from
these investigations will provide a novel avenue for the
identiﬁcation and development of miRNAs as ‘‘molecular
tools’’, with the potential to identify novel molecular
pathways involved in synaptic maintenance and generate
new molecular-based therapies to treat diseases of the
central nervous system.
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Table 2 An overview of selected miRNAs associated with neurological disorders
miRNA Disease Dysregulation Target Consequence of miRNA dysregulation Reference
miR-9/9* Huntington
disease
Downregulated REST (miR-9) Excessive amount of REST and
CoREST in the nucleus
[119]
CoREST (miR-9*) Inactivation of neuron-speciﬁc genes
miR-29a AD Downregulated NAV3 NAV3 coexpressed tau neuroﬁbrillary
tangles in pyramidal neurons
[120]
miR-29a,-29b-1 Sporadic AD Downregulated BACE1 Increase of amyloid-b [121]
miR-106b AD Downregulated APP Increase of amyloid-b [111]
miR-107 AD Downregulated BACE1 Increase of amyloid-b [122]
miR-124 FXS Downregulated Decreased neuronal maturation [105]
miR-133b PD Upregulated Pitx3 Repression of neuronal maturation [112]
miR-146a/b Rett syndrome Downregulated Irak1 An increase in the amount of Irak1 puts
the brain into an inﬂammatory state
[123]
miR-181b Schizophrenia Upregulated in
prefrontal cortex
GRIA2 Decrease in neuronal outgrowth [107]
VSNL1
miR-298 and -328 AD Unknown BACE1 Increase of amyloid-b [124]
miR-342-3p Prion disease Upregulated [125]
miR-485-5p AD Downregulated in entorhinal
cortex and hippocampus
BACE1 Increase of amyloid-b [110]
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